ID

38126

Descripción

Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01788839

Link

https://clinicaltrials.gov/show/NCT01788839

Palabras clave

Versiones (1)
  1. 20/9/19 20/9/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

20 de septiembre de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Breast Cancer NCT01788839

Inglés

Eligibility Breast Cancer NCT01788839

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
subject inclusion criteria for cohort of premenopausal women with early stage breast cancer and lymphoma
Descripción

Premenopausal state | Early-Stage Breast Carcinoma | Lymphoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232969
UMLS CUI [2]
C2986665
UMLS CUI [3]
C0024299
premenopausal women at time of diagnosis ages 18 to 50 who have either been pregnant or had at least one menstrual period in the last 12 months
Descripción

Premenopausal state | Age | Pregnancy | Menstrual cycle Quantity Timespan

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232969
UMLS CUI [2]
C0001779
UMLS CUI [3]
C0032961
UMLS CUI [4,1]
C0025329
UMLS CUI [4,2]
C1265611
UMLS CUI [4,3]
C0872291
women with newly diagnosed breast cancer (stage 0-iii) who are within 1 month of starting systemic treatment or women with any aggressive lymphoma being treated with first line therapy with curative intent.
Descripción

Gender | Breast Carcinoma TNM Breast tumor staging | Systemic therapy | First line treatment Curative Aggressive Lymphoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2,1]
C0678222
UMLS CUI [2,2]
C0474926
UMLS CUI [3]
C1515119
UMLS CUI [4,1]
C1708063
UMLS CUI [4,2]
C1276305
UMLS CUI [4,3]
C1332225
breast cancer patients with any receptor type
Descripción

Breast Carcinoma | Receptor Type Any

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0678222
UMLS CUI [2,1]
C0597357
UMLS CUI [2,2]
C0332307
UMLS CUI [2,3]
C1552551
english speaking
Descripción

Able to speak English Language

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0564215
UMLS CUI [1,2]
C0376245
able to participate in the informed consent process
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
subject inclusion criteria for cohort of postmenopausal women with early stage breast cancer and lymphoma
Descripción

Postmenopausal state | Early-Stage Breast Carcinoma | Lymphoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232970
UMLS CUI [2]
C2986665
UMLS CUI [3]
C0024299
postmenopausal women at time of diagnosis > age 50 who have been without period for ≥ 2 years.
Descripción

Postmenopausal state | Age | Menstruation Absent Duration

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232970
UMLS CUI [2]
C0001779
UMLS CUI [3,1]
C0025344
UMLS CUI [3,2]
C0332197
UMLS CUI [3,3]
C0449238
women with newly diagnosed breast cancer (stage 0-iii) who are within 1 month of starting systemic treatment or women with any aggressive lymphoma being treated with first line therapy with curative intent.
Descripción

Gender | Breast Carcinoma TNM Breast tumor staging | Systemic therapy | First line treatment Curative Aggressive Lymphoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2,1]
C0678222
UMLS CUI [2,2]
C0474926
UMLS CUI [3]
C1515119
UMLS CUI [4,1]
C1708063
UMLS CUI [4,2]
C1276305
UMLS CUI [4,3]
C1332225
breast cancer patients with any receptor type
Descripción

Breast Carcinoma | Receptor Type Any

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0678222
UMLS CUI [2,1]
C0597357
UMLS CUI [2,2]
C0332307
UMLS CUI [2,3]
C1552551
english speaking
Descripción

Able to speak English Language

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0564215
UMLS CUI [1,2]
C0376245
able to participate in the informed consent process
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
subject exclusion criteria for both pre and postmenopausal women with early stage breast cancer and lymphoma
Descripción

Exclusion Criteria | Premenopausal state | Postmenopausal state | Early-Stage Breast Carcinoma | Lymphoma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2]
C0232969
UMLS CUI [3]
C0232970
UMLS CUI [4]
C2986665
UMLS CUI [5]
C0024299
active secondary cancer requiring cytotoxic chemotherapy
Descripción

Secondary Neoplasm Requirement Cytotoxic Chemotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2939419
UMLS CUI [1,2]
C1514873
UMLS CUI [1,3]
C0677881
prior systemic treatment for a malignancy
Descripción

Systemic therapy Malignant Neoplasms

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1515119
UMLS CUI [1,2]
C0006826
Volver a la parte superior de la página

Similar models

Eligibility Breast Cancer NCT01788839

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Premenopausal state | Early-Stage Breast Carcinoma | Lymphoma
Item
subject inclusion criteria for cohort of premenopausal women with early stage breast cancer and lymphoma
boolean
C0232969 (UMLS CUI [1])
C2986665 (UMLS CUI [2])
C0024299 (UMLS CUI [3])
Premenopausal state | Age | Pregnancy | Menstrual cycle Quantity Timespan
Item
premenopausal women at time of diagnosis ages 18 to 50 who have either been pregnant or had at least one menstrual period in the last 12 months
boolean
C0232969 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0032961 (UMLS CUI [3])
C0025329 (UMLS CUI [4,1])
C1265611 (UMLS CUI [4,2])
C0872291 (UMLS CUI [4,3])
Gender | Breast Carcinoma TNM Breast tumor staging | Systemic therapy | First line treatment Curative Aggressive Lymphoma
Item
women with newly diagnosed breast cancer (stage 0-iii) who are within 1 month of starting systemic treatment or women with any aggressive lymphoma being treated with first line therapy with curative intent.
boolean
C0079399 (UMLS CUI [1])
C0678222 (UMLS CUI [2,1])
C0474926 (UMLS CUI [2,2])
C1515119 (UMLS CUI [3])
C1708063 (UMLS CUI [4,1])
C1276305 (UMLS CUI [4,2])
C1332225 (UMLS CUI [4,3])
Breast Carcinoma | Receptor Type Any
Item
breast cancer patients with any receptor type
boolean
C0678222 (UMLS CUI [1])
C0597357 (UMLS CUI [2,1])
C0332307 (UMLS CUI [2,2])
C1552551 (UMLS CUI [2,3])
Able to speak English Language
Item
english speaking
boolean
C0564215 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
Informed Consent
Item
able to participate in the informed consent process
boolean
C0021430 (UMLS CUI [1])
Postmenopausal state | Early-Stage Breast Carcinoma | Lymphoma
Item
subject inclusion criteria for cohort of postmenopausal women with early stage breast cancer and lymphoma
boolean
C0232970 (UMLS CUI [1])
C2986665 (UMLS CUI [2])
C0024299 (UMLS CUI [3])
Postmenopausal state | Age | Menstruation Absent Duration
Item
postmenopausal women at time of diagnosis > age 50 who have been without period for ≥ 2 years.
boolean
C0232970 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0025344 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0449238 (UMLS CUI [3,3])
Gender | Breast Carcinoma TNM Breast tumor staging | Systemic therapy | First line treatment Curative Aggressive Lymphoma
Item
women with newly diagnosed breast cancer (stage 0-iii) who are within 1 month of starting systemic treatment or women with any aggressive lymphoma being treated with first line therapy with curative intent.
boolean
C0079399 (UMLS CUI [1])
C0678222 (UMLS CUI [2,1])
C0474926 (UMLS CUI [2,2])
C1515119 (UMLS CUI [3])
C1708063 (UMLS CUI [4,1])
C1276305 (UMLS CUI [4,2])
C1332225 (UMLS CUI [4,3])
Breast Carcinoma | Receptor Type Any
Item
breast cancer patients with any receptor type
boolean
C0678222 (UMLS CUI [1])
C0597357 (UMLS CUI [2,1])
C0332307 (UMLS CUI [2,2])
C1552551 (UMLS CUI [2,3])
Able to speak English Language
Item
english speaking
boolean
C0564215 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
Informed Consent
Item
able to participate in the informed consent process
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Exclusion Criteria | Premenopausal state | Postmenopausal state | Early-Stage Breast Carcinoma | Lymphoma
Item
subject exclusion criteria for both pre and postmenopausal women with early stage breast cancer and lymphoma
boolean
C0680251 (UMLS CUI [1])
C0232969 (UMLS CUI [2])
C0232970 (UMLS CUI [3])
C2986665 (UMLS CUI [4])
C0024299 (UMLS CUI [5])
Secondary Neoplasm Requirement Cytotoxic Chemotherapy
Item
active secondary cancer requiring cytotoxic chemotherapy
boolean
C2939419 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
C0677881 (UMLS CUI [1,3])
Systemic therapy Malignant Neoplasms
Item
prior systemic treatment for a malignancy
boolean
C1515119 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial